COVID-19 and private drug sellers in Indonesia: a sub-study

Credit: RomoloTavani

The PINTAR research team are undertaking a national survey of all registered community pharmacies and drug stores across Indonesia to help improve the quality of care offered by private drug sellers (PDS) during the current COVID-19 outbreak and any future pandemics.

This sub-study will analyse the PDS’ understanding of the COVID-19 pandemic, the medicines and advice given to clients, and possible actions to improve COVID-19 management practices in the private sector.

As the PINTAR study evolved, it became clear that the inappropriate use of antibiotics amongst PDS in Indonesia is a widespread problem. The pandemic could aggravate the situation by increasing practices of unnecessary self-medication and irrational use and hoarding of antimicrobial drugs (such as antivirals, antimalarials and antibiotics).

The PINTAR team are carrying out the additional sub-study with the support from PDS and the Indonesian Pharmacy Associations with whom they have been working since 2018.

The mixed-methods study aims to investigate the PDS’ knowledge and understanding of COVID-19, including their sources of information; the advice and medicines that PDS give to clients; the interactions and expectations between PDS and clients; measures taken by PDS to protect the staff at pharmacies and outlets from COVID-19; and any immediate actions that could be taken to improve COVID-19 management practices.

To the best of the PINTAR Team’s knowledge, this is the first study in Indonesia exploring the impact of COVID-19 in the practices of PDS in Indonesia. The research will be done through a nationwide online survey of all registered PDS and telephone interviews with a sub-sample of survey participants.

Related information:

Share This Article

Leave a Comment

Latest From Our Blog
Blog Categories
PINTAR Newsletter

If you wish to receive updates on how the PINTAR Study is progressing, we invite you to subscribe to the PINTAR newsletter.